Rocky Mountain Laboratories

Jul 21, 2023 | academic.oup.com | Rocky Mountain Laboratories

Ebola virus (EBOV), strain Makona, infected more than 30,000 people from 2013-2016 in West Africa, among them many health care workers including foreign nationals. Most of the infected foreign nationals were evacuated and treated in their respective home countries resulting in detailed reports of the acute disease following EBOV infection as well as descriptions of symptoms now known as “Post-Ebola Syndrome” which occurred months after the infection.

Jun 22, 2023 | academic.oup.com | Rocky Mountain Laboratories

When you visit web sites, they may store or retrieve data in your web browser. This storage is often necessary for basic functionality of the web site or the storage may be used for the purposes of marketing, analytics, and personalization of the web site such as storing your preferences.

Jun 8, 2023 | academic.oup.com | Rocky Mountain Laboratories

When you visit web sites, they may store or retrieve data in your web browser. This storage is often necessary for basic functionality of the web site or the storage may be used for the purposes of marketing, analytics, and personalization of the web site such as storing your preferences.

Apr 19, 2023 | journals.plos.org | Megan O’Connor |David W Hawman |Rocky Mountain Laboratories |PLOS Pathogens

The repRNA-CoV2S vaccine affords durable protection from SARS-CoV-2 induced clinical disease and pathologyWe next evaluated the ability of the vaccine to protect from clinical disease and lung pathology. Animals were comprehensively evaluated by trained research staff for evidence of disease including reduced appetite, lethargy, respiratory distress, and general appearance. The most common clinical observations among unvaccinated animals were lethargy, abnormal respiration, and nasal discharge.